The implementation of the family doctor plan is considered a foundational measure and a significant advancement in the health insurance sector in Iran. It aims to improve the provision of healthcare services and streamline the referral system, with the most important outcomes being the reduction of confusion among people seeking medical care and an increase in their satisfaction with health services (
1). The design and implementation of the family doctor program have been part of the country’s health system since 2014, with the goal of reducing disparities and ensuring equitable access to available facilities. This program also facilitates the fair distribution of health services across less populated areas of the country. In Iran, level-one services have an average per capita cost of 1,210,000 rials per year, with pharmaceutical services and supplements accounting for 13.5% and 4% of this expenditure, respectively. The family doctor program introduced a medication prescribing framework, limiting doctors to prescribing drugs within a defined list (
2).
Providing medicine is an essential component of primary healthcare and a government obligation. Medical services, both outpatient and inpatient, hold a special place due to the influence of various economic, social, and cultural factors that have made drug therapy the primary method for disease prevention and treatment in society. To ensure the availability of effective, safe, high-quality medications at prices affordable for both the government and the public, each country needs a national drug policy as part of its overall health policy. Reforming pharmaceutical policy in developing countries is among the most critical areas of health sector reform, with the World Bank and the World Health Organization agreeing on the necessity of reorganization (
3).
The Ministry of Health, Medicine, and Medical Education, in its efforts to rationalize government size, strengthen accountability, and enhance the efficiency of health services and medical education, has implemented measures aligned with Note 5, Article 2 of the 1982 budget executive regulations and the third development law. These measures aim to reduce public service tenure and optimize resource utilization through continuous monitoring. As part of this initiative, the ministry implemented a plan to reduce contracting and outsourcing in support services across 41 pilot hospitals (
4). Outsourcing refers to transferring services or functions traditionally performed by the organization to an external supplier, managed through a contract or cooperative agreement (
5), according to the theories of Lacitti and Cox. During outsourcing, attention should be given to factors such as the scope and activities outsourced, evaluation methods (e.g., lack of evaluation, supplier performance comparison, or internal activity review), supplier comparisons, contract type (e.g., standard, detailed, combined, strategic cooperation), contract duration (< 3, 3 - 8, > 8 years), contract timing, and satisfaction levels (e.g., full, partial, lack of satisfaction, or undefined satisfaction) (
6).
According to Mugin, global revenue for pharmaceutical factories outsourced in 2004 was approximately 100$ billion, growing to 168$ billion by 2009 at a rate of 10.8% (
7). A comparison of employee satisfaction levels before and after pharmacy handovers indicates improvements in areas such as the delivery of drugs and equipment, quality enhancement, and staff satisfaction. Issues related to staff attitudes, problem-solving capabilities, the elimination of expired drugs, and, most importantly, the provision of rare medications have been addressed, contributing significantly to improved staff satisfaction and service quality (
8).
For various reasons, organizations have consistently shown enthusiasm for breaking down their structures into smaller units and cells by outsourcing their activities. The primary reasons for outsourcing can be summarized as follows: Limited time, high costs, better quality, prioritizing vital activities, cost reduction, weak performance of internal units, and the non-vital nature of certain outsourced activities. Other factors include the need to carry out activities beyond the organization’s expertise, insufficient specialization within the organization to provide specific services or products, lack of potential control over certain internal activities, the existence of services and activities not aligned with the organization’s long-term goals, previous successes in outsourcing external activities, creating an environment conducive to internal changes, and limited financial resources or capital required for new technical investments (
7).
Outsourcing can also improve responsiveness, transparency, and legitimacy within the system by stabilizing service provision through local management systems, increasing citizen participation in service delivery by creating systems that encourage their involvement in planning, resource allocation, monitoring, and service evaluation. Additionally, it can promote justice in service delivery by enabling poor and marginalized populations to access healthcare providers and enhance the private sector's role in healthcare provision by separating the financial responsibility for services from their delivery—key goals of decentralization (
9). Outsourcing reduces costs, enhances organizational focus on core activities, provides opportunities to streamline internal processes, mitigates risks by partnering with external units in uncertain business environments, improves customer service, reduces employee numbers, and fosters competition within different organizational segments, addressing inefficiencies (
10).
In Iran, recent years have seen an emphasis on outsourcing healthcare services to the private sector to improve quality, enhance patient satisfaction, and reduce costs. This approach has been particularly prominent in the field of pharmaceutical services within medical centers (
11). Globally, the ineffectiveness of drug supply management systems managed by governments has been identified, and transitioning these services to the private sector or involving private sector partnerships has been proposed and implemented as a solution (
12).
In the outsourcing model of pharmaceutical services in health and treatment centers affiliated with medical universities, three medical service insurance organizations act as financial resource providers and buyers. These organizations purchase health service packages from city health and treatment networks, which, based on local conditions, may hand over pharmaceutical services in subordinate medical health centers to the private sector (secondary buyer role) (
13).
Pharmacies, as profitable units, when handed over to the private sector, can not only maintain their original quality and minimize production costs but also generate higher profits for organizations (
14). In Iran, outsourcing is still in its early stages, particularly in the health sector, where awareness and experience regarding this phenomenon are limited. There has been no comprehensive assessment of the appropriate types of outsourcing contracts or the outcomes of outsourcing in units such as pharmacies (
15).